Works by Chuang, Wan‐Long


Results: 154
    1

    A Phase 3 clinical trial validating the potency and safety of an innovative, extra‐long‐acting interferon in chronic hepatitis C.

    Published in:
    JGH Open, 2022, v. 6, n. 11, p. 782, doi. 10.1002/jgh3.12825
    By:
    • Chen, Chi‐Yi;
    • Chuang, Wan‐Long;
    • Qin, Albert;
    • Zhang, Wen‐Hua;
    • Zhu, Li‐Ying;
    • Zhang, Guo‐Qiang;
    • Chen, Jyh‐Jou;
    • Lo, Ching‐Chu;
    • Zhou, Xinmin;
    • Mao, Xiaorong;
    • Shang, Jia;
    • Kuo, Hsing‐Tao;
    • Xie, Wen;
    • Chen, Chien‐Hung;
    • Lo, Gin‐Ho;
    • Jun, Dae W;
    • Dang, Shuangsuo;
    • Tsai, Chan‐Yen;
    • Wang, Ting‐Fang;
    • Lai, Hsin‐Hui
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Viral Interference Between Dengue Virus and Hepatitis C Virus Infections.

    Published in:
    Open Forum Infectious Diseases, 2020, v. 7, n. 8, p. 1, doi. 10.1093/ofid/ofaa272
    By:
    • Liang, Po-Cheng;
    • Chen, Kuan-Yu;
    • Huang, Chung-Hao;
    • Chang, Ko;
    • Lu, Po-Liang;
    • Yeh, Ming-Lun;
    • Huang, Chung-Feng;
    • Huang, Ching-I;
    • Hsieh, Meng-Hsuan;
    • Dai, Chia-Yen;
    • Lin, Zu-Yau;
    • Chen, Shinn-Chern;
    • Chuang, Wan-Long;
    • Chen, Yen-Hsu;
    • Huang, Jee-Fu;
    • Yu, Ming-Lung
    Publication type:
    Article
    11
    12

    Air Pollution Associated With Mortality Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 9, p. 1458, doi. 10.1111/apt.70019
    By:
    • Jang, Tyng‐Yuan;
    • Zeng, Yu‐Ting;
    • Liang, Po‐Cheng;
    • Wu, Chih‐Da;
    • Wei, Yu‐Ju;
    • Tsai, Pei‐Chien;
    • Hsieh, Ming‐Yen;
    • Lin, Yi‐Hung;
    • Hsieh, Meng‐Hsuan;
    • Wang, Chih‐Wen;
    • Yang, Jeng‐Fu;
    • Yeh, Ming‐Lun;
    • Huang, Chung‐Feng;
    • Chuang, Wan‐Long;
    • Huang, Jee‐Fu;
    • Cheng, Ya‐Yun;
    • Dai, Chia‐Yen;
    • Chen, Pau‐Chung;
    • Yu, Ming‐Lung
    Publication type:
    Article
    13

    Eight‐year efficacy and safety of tenofovir alafenamide for treatment of chronic hepatitis B virus infection: Final results from two randomised phase 3 trials.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 11/12, p. 1573, doi. 10.1111/apt.18278
    By:
    • Buti, Maria;
    • Lim, Young‐Suk;
    • Chan, Henry Lik Yuen;
    • Agarwal, Kosh;
    • Marcellin, Patrick;
    • Brunetto, Maurizia R.;
    • Chuang, Wan‐Long;
    • Janssen, Harry L. A.;
    • Fung, Scott K.;
    • Izumi, Namiki;
    • Jablkowski, Maciej S.;
    • Abdurakhmanov, Dzhamal;
    • Abramov, Frida;
    • Wang, Hongyuan;
    • Botros, Irina;
    • Yee, Leland J.;
    • Mateo, Roberto;
    • Flaherty, John F.;
    • Osinusi, Anu;
    • Pan, Calvin Q.
    Publication type:
    Article
    14
    15

    Editorial: increasing burden of nonalcoholic fatty liver disease—a call to action. Authors' reply.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1430, doi. 10.1111/apt.15718
    By:
    • Estes, Chris;
    • Chan, Henry L. Y.;
    • Chien, Rong N.;
    • Chuang, Wan‐Long;
    • Fung, James;
    • Goh, George Boon‐Bee;
    • Hu, Tsung H.;
    • Huang, Jee‐Fu;
    • Jang, Byoung K.;
    • Jun, Dae W.;
    • Kao, Jia H.;
    • Lee, Jin‐Woo;
    • Lin, Han‐Chieh;
    • Razavi‐Shearer, Kathryn;
    • Seto, Wai‐Kay;
    • Wong, Grace L.‐H.;
    • Wong, Vincent W.‐S.;
    • Razavi, Homie
    Publication type:
    Article
    16

    Modelling NAFLD disease burden in four Asian regions—2019‐2030.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 8, p. 801, doi. 10.1111/apt.15673
    By:
    • Estes, Chris;
    • Chan, Henry L. Y.;
    • Chien, Rong N.;
    • Chuang, Wan‐Long;
    • Fung, James;
    • Goh, George Boon-Bee;
    • Hu, Tsung H.;
    • Huang, Jee‐Fu;
    • Jang, Byoung K.;
    • Jun, Dae W.;
    • Kao, Jia H.;
    • Lee, Jin‐Woo;
    • Lin, Han‐Chieh;
    • Razavi‐Shearer, Kathryn;
    • Seto, Wai‐Kay;
    • Wong, Grace L. ‐H.;
    • Wong, Vincent W. ‐S.;
    • Razavi, Homie
    Publication type:
    Article
    17
    18
    19
    20
    21
    22

    Twelve weeks of ledipasvir/sofosbuvir all‐oral regimen for patients with chronic hepatitis C genotype 2 infection: Integrated analysis of three clinical trials.

    Published in:
    Hepatology Research, 2020, v. 50, n. 10, p. 1109, doi. 10.1111/hepr.13546
    By:
    • Asahina, Yasuhiro;
    • Liu, Chun‐Jen;
    • Gane, Edward;
    • Itoh, Yoshito;
    • Kawada, Norifumi;
    • Ueno, Yoshiyuki;
    • Youn, Jin;
    • Wang, Chen‐Yu;
    • Llewellyn, Joe;
    • Matsuda, Takuma;
    • Gaggar, Anuj;
    • Mo, Hongmei;
    • Dvory‐Sobol, Hadas;
    • Crans, Gerald;
    • Chuang, Wan‐Long;
    • Chen, Pei‐Jer;
    • Enomoto, Nobuyuki
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus.

    Published in:
    Journal of Gastroenterology & Hepatology, 2016, v. 31, n. 7, p. 1323, doi. 10.1111/jgh.13305
    By:
    • Chuang, Wan‐Long;
    • Chien, Rong‐Nan;
    • Peng, Cheng‐Yuan;
    • Chang, Ting‐Tsung;
    • Lo, Gin‐Ho;
    • Sheen, I‐Shyan;
    • Wang, Horng‐Yuan;
    • Chen, Jyh‐Jou;
    • Yang, Jenny C.;
    • Knox, Steven J.;
    • Gao, Bing;
    • Garrison, Kimberly L.;
    • Mo, Hongmei;
    • Pang, Phillip S.;
    • Hsu, Yu‐Chun;
    • Hu, Tsung‐Hui;
    • Chu, Chi‐Jen;
    • Kao, Jia‐Horng
    Publication type:
    Article
    36
    37

    The tertiary prevention of hepatocellular carcinoma in chronic hepatitis C patients.

    Published in:
    Journal of Gastroenterology & Hepatology, 2015, v. 30, n. 12, p. 1768, doi. 10.1111/jgh.13012
    By:
    • Huang, Jee‐Fu;
    • Yeh, Ming‐Lun;
    • Yu, Ming‐Lung;
    • Dai, Chia‐Yen;
    • Huang, Chung‐Feng;
    • Huang, Ching‐I;
    • Tsai, Pei‐Chien;
    • Lin, Pei‐Chen;
    • Chen, Yao‐Li;
    • Chang, Wen‐Tsan;
    • Hou, Nai‐Jen;
    • Lin, Zu‐Yau;
    • Chen, Shinn‐Cherng;
    • Chuang, Wan‐Long
    Publication type:
    Article
    38

    Chronic hepatitis C infection is associated with insulin resistance and lipid profiles.

    Published in:
    Journal of Gastroenterology & Hepatology, 2015, v. 30, n. 5, p. 879, doi. 10.1111/jgh.12313
    By:
    • Dai, Chia‐Yen;
    • Yeh, Ming‐Lun;
    • Huang, Chung‐Feng;
    • Hou, Chen‐Hsiu;
    • Hsieh, Ming‐Yen;
    • Huang, Jee‐Fu;
    • Lin, I‐Ling;
    • Lin, Zu‐Yau;
    • Chen, Shinn‐Chern;
    • Wang, Liang‐Yen;
    • Chuang, Wan‐Long;
    • Yu, Ming‐Lung;
    • Tung, Hung‐Da
    Publication type:
    Article
    39
    40

    Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection.

    Published in:
    Journal of Gastroenterology & Hepatology, 2015, v. 30, n. 1, p. 184, doi. 10.1111/jgh.12671
    By:
    • Colvin, Richard A;
    • Tanwandee, Tawesak;
    • Piratvisuth, Teerha;
    • Thongsawat, Satawat;
    • Hui, Aric Josun;
    • Zhang, Hongfei;
    • Ren, Hong;
    • Chen, Pei‐Jer;
    • Chuang, Wan‐Long;
    • Sobhonslidsuk, Abhasnee;
    • Li, Ruobing;
    • Qi, Yin;
    • Praestgaard, Jens;
    • Han, Yi;
    • Xu, Junfang;
    • Stein, Daniel S
    Publication type:
    Article
    41
    42
    43

    Clinical utility of host genetic IL-28 B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin.

    Published in:
    Journal of Gastroenterology & Hepatology, 2013, v. 28, n. 9, p. 1515, doi. 10.1111/jgh.12211
    By:
    • Huang, Chung‐Feng;
    • Yeh, Ming‐Lun;
    • Hsieh, Meng‐Hsuan;
    • Hsieh, Ming‐Yen;
    • Lin, Zu‐Yau;
    • Chen, Shinn‐Cherng;
    • Wang, Liang‐Yen;
    • Huang, Jee‐Fu;
    • Juo, Suh‐Hang Hank;
    • Lin, Yi‐Ching;
    • Dai, Chia‐Yen;
    • Chuang, Wan‐Long;
    • Yu, Ming‐Lung
    Publication type:
    Article
    44

    Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients.

    Published in:
    Journal of Gastroenterology & Hepatology, 2011, v. 26, n. 7, p. 1182, doi. 10.1111/j.1440-1746.2011.06722.x
    By:
    • Patel, Keyur;
    • Thompson, Alexander J;
    • Chuang, Wan-Long;
    • Lee, Chuan-Mo;
    • Peng, Chen-Yuan;
    • Shanmuganathan, Ganesananthan;
    • Thongsawat, Satawat;
    • Tanwandee, Tawesak;
    • Mahachai, Varocha;
    • Pramoolsinsap, Chutima;
    • Cho, Mong;
    • Han, Kwang Hyup;
    • Shah, Samir R;
    • Foster, Graham R;
    • Clark, Paul J;
    • Pulkstenis, Erik;
    • Subramanian, G. Mani;
    • McHutchison, John G
    Publication type:
    Article
    45
    46

    Incidence and clinical outcome of icteric type hepatocellular carcinoma.

    Published in:
    Journal of Gastroenterology & Hepatology, 2002, v. 17, n. 2, p. 190, doi. 10.1046/j.1440-1746.2002.02677.x
    By:
    • HUANG, JEE-FU;
    • WANG, LIANG-YEN;
    • LIN, ZU-YAU;
    • CHEN, SHINN-CHERN;
    • HSIEH, MING-YUH;
    • CHUANG, WAN-LONG;
    • YU, MING-LUNG;
    • LU, SHENG-NAN;
    • WANG, JING-HOUNG;
    • YEUNG, KWOK-WAN;
    • CHANG, WEN-YU
    Publication type:
    Article
    47
    48
    49
    50